Item 3: Drugs and Biologicals, Medical Supplies, and Durable Medical Equipment (§ 418.106(e)(2)(i))
The CoP require hospices, at §418.106(e)(2)), to:
(1) Provide a copy of the hospice written policies and procedures on the management and disposal of controlled drugs to the patient or patient representative and family;
(2) Discuss the hospice policies and procedures for managing the safe use and disposal of controlled drugs with the patient or representative and the family in a language and manner that they understand to ensure that these parties are educated regarding the safe use and disposal of controlled drugs; and
(3) Document in the patient’s clinical record that the written policies and procedures for managing controlled drugs was provided and discussed.
While CMS believes this requirement is still relevant for internal hospice use, the agency has concerns that patients and family members may find hospice policies and procedures difficult to understand, and also believes that a hard copy of this information may not in all cases be the best means for supplying the information. In lieu of existing requirements CMS is proposing to replace the requirement that hospices provide a physical paper copy of policies and procedures with a requirement that hospices provide information regarding the use, storage, and disposal of controlled drugs to the patient or patient representative, and family, which can be developed in a more user-friendly form, as decided by each hospice. CMS proposes to require that, regardless of the format chosen, this information must be provided to patients and families in a manner that allows for continual access to the information on an as-needed basis in order to assure that patients and families have information available when they need it. CMS is soliciting input concerning what a standardized educational format should entail, including whether the format should be paper or electronic; in writing, pictorial, video, or audio; what general subjects should be addressed in regards to storage, disposal, use, and risks; and what specific content should be included to minimize opioid diversion and maximize safety.